Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The murine MHC-E molecule Qa-1<sup>b</sup> is surface displayed in a peptide-free conformation in homeostasis.

Frontiers in immunology·2026
Same author

Setting higher standards for reports of microbial species in human cancers.

Nature cancer·2026
Same author

Metabolic engineering of doxorubicin biosynthesis through P450-redox partner optimization and structural analysis of DoxA.

Nature communications·2026
Same author

The trajectory of fatigue over time in breast cancer patients treated with chemotherapy: exploring the effect of anthracycline-based chemotherapy.

Breast (Edinburgh, Scotland)·2026
Same author

Cell cycle arrest enhances CD8<sup>+</sup> T cell effector function by potentiating glucose metabolism and IL-2 signaling.

Nature immunology·2026
Same author

Determining Preclinical Safety of Aclarubicin in Pediatric Malignancies.

Pediatric blood & cancer·2025

Related Experiment Video

Updated: Jun 10, 2026

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells
09:32

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Published on: February 8, 2018

Coupled for cross-presentation in tumor immunotherapy.

Baoxu Pang1, Jacques Neefjes

  • 1Division of Cell Biology, Netherlands Cancer Institute, 1066CX Amsterdam, Netherlands.

Science Translational Medicine
|August 13, 2010
PubMed
Summary

Salmonella infection enhances tumor antigen transfer to antigen-presenting cells via gap junctions. This promotes cross-presentation, boosting cell-mediated immunity for effective tumor eradication.

Area of Science:

  • Immunology
  • Oncology
  • Microbiology

Background:

  • Antigen cross-presentation is vital for cell-mediated immunity.
  • Improving tumor immunotherapy and vaccination relies on manipulating antigen cross-presentation.

Purpose of the Study:

  • To investigate a novel mechanism for enhancing antitumor responses.
  • To explore Salmonella's role in promoting antigen cross-presentation in melanoma.

Main Methods:

  • Inducing Salmonella infection in melanoma tumors.
  • Analyzing the transfer of tumor-specific antigens to antigen-presenting cells.
  • Evaluating the impact on cross-presentation and immune response.

Main Results:

  • Salmonella infection induces gap junctions in cancer cells.

More Related Videos

Multiplex Immunofluorescence Combined with Spatial Image Analysis for the Clinical and Biological Assessment of the Tumor Microenvironment
06:05

Multiplex Immunofluorescence Combined with Spatial Image Analysis for the Clinical and Biological Assessment of the Tumor Microenvironment

Published on: June 2, 2023

Co-Culture In Vitro Systems to Reproduce the Cancer-Immunity Cycle
12:19

Co-Culture In Vitro Systems to Reproduce the Cancer-Immunity Cycle

Published on: June 7, 2024

Related Experiment Videos

Last Updated: Jun 10, 2026

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells
09:32

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Published on: February 8, 2018

Multiplex Immunofluorescence Combined with Spatial Image Analysis for the Clinical and Biological Assessment of the Tumor Microenvironment
06:05

Multiplex Immunofluorescence Combined with Spatial Image Analysis for the Clinical and Biological Assessment of the Tumor Microenvironment

Published on: June 2, 2023

Co-Culture In Vitro Systems to Reproduce the Cancer-Immunity Cycle
12:19

Co-Culture In Vitro Systems to Reproduce the Cancer-Immunity Cycle

Published on: June 7, 2024

  • Tumor antigens are transferred to antigen-presenting cells via these gap junctions.
  • Enhanced cross-presentation leads to robust antitumor immunity and tumor eradication.

    • Conclusions:

    • Salmonella infection can be leveraged to enhance antigen cross-presentation.
    • This mechanism offers a promising strategy for improving cancer immunotherapy.
    • Targeting Salmonella-induced gap junctions may overcome challenges in tumor eradication.